...
首页> 外文期刊>Journal of Neuroimmunology: Official Bulletin of the Research Committee on Neuroimmunology of the World Federation of Neurology >Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease.
【24h】

Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease.

机译:细胞因子产生的单细胞分析显示,患有活动性或静止性疾病的多发性硬化症患者具有不同的免疫特征。

获取原文
获取原文并翻译 | 示例
           

摘要

Peripheral blood mononuclear cells of multiple sclerosis (MS) patients were stimulated with myelin basic protein (MBP) together with anti-CD28 monoclonal antibody and staphylococcal enterotoxin B to optimize cytokine production by antigen-specific cells. Type 1 (IL-2, IL-12, IFNgamma) and pro-inflammatory (TNFalpha, IL-1beta, IL-6) cytokines were augmented in CD4+, CD8+, and CD14+ cells of acute MS patients and of patients undergoing disease reactivation. These cytokines were reduced in IFNbeta-treated and in stable MS patients; type 2 cytokines (IL-4, IL-10) were increased in these patients. Similar immune profiles are seen in MS patients in whom remission is naturally or pharmacologically (IFNbeta) achieved. Cytokine alterations are particularly evident in CD14+ cells, underlying their critical role in the modulation of the immune response.
机译:多发性硬化症(MS)患者的外周血单核细胞用髓磷脂碱性蛋白(MBP)以及抗CD28单克隆抗体和葡萄球菌肠毒素B刺激,以优化抗原特异性细胞的细胞因子产生。在急性MS患者和经历疾病再激活的患者的CD4 +,CD8 +和CD14 +细胞中,增加了1型(IL-2,IL-12,IFNγ)和促炎性(TNFα,IL-1beta,IL-6)细胞因子。在IFNβ治疗和稳定的MS患者中,这些细胞因子减少了。这些患者的2型细胞因子(IL-4,IL-10)升高。在自然或药理学上已达到缓解(MS)的MS患者中,可以看到类似的免疫特征。细胞因子的改变在CD14 +细胞中尤其明显,这是它们在调节免疫应答中的关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号